Capital Impact Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arhaus
ARHS
|
+$228K |
| 2 |
Antero Resources
AR
|
+$208K |
| 3 |
Matador Resources
MTDR
|
+$203K |
| 4 |
Shutterstock
SSTK
|
+$194K |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$188K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
e.l.f. Beauty
ELF
|
+$919K |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$772K |
| 3 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$637K |
| 4 |
Enphase Energy
ENPH
|
+$535K |
| 5 |
Meta Platforms (Facebook)
META
|
+$528K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.49% |
| 2 | Healthcare | 26.32% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Industrials | 8.94% |
| 5 | Financials | 6.81% |
Similar funds
Capital Impact Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Impact Advisors held 238 positions worth $100M, down 7.2% from $108M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Capital Impact Advisors withdrew a net $11.3M in Q3 2022, closing 1 position and reducing 117 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $772K position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Capital Impact Advisors opened a new position in Ginkgo Bioworks worth $118K.
- Capital Impact Advisors's largest Q3 2022 buy was Ginkgo Bioworks: 1,374 shares worth $118K.
- Capital Impact Advisors added most to Arhaus in Q3 2022, an estimated $228K increase.
- Capital Impact Advisors's biggest Q3 2022 reduction was e.l.f. Beauty, cutting an estimated $919K.
- Capital Impact Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $772K.
- Capital Impact Advisors's ten largest holdings make up 12% of its $100M portfolio in Q3 2022.
- Capital Impact Advisors opened 12 new positions and closed 1 in Q3 2022.
- Capital Impact Advisors's portfolio value fell 7.2% quarter-over-quarter to $100M.
Based on Capital Impact Advisors's 13F filing for Q3 2022, filed 22 Nov 2022.